IOL

One year after implantation, the enduring IOP reduction remained consistent across all 3 dose strengths.

Alice Epitropoulos, MD, discusses the importance of considering ocular surface health in cataract surgery patients.

The company’s EVO family of Implantable Collamer Lenses for myopia, astigmatism and presbyopia, are designed to correct vision through a minimally invasive procedure.

The Clareon platform will be available in India in 2 Presbyopia correcting IOL technologies: the Clareon PanOptix and Clareon Vivity.

According to the company, the milestone underscores Vivity’s wavefront-shaping technology, which simplifies presbyopia correction for surgeons and patients.

Sydney Tyson, MD, MPH concludes this series discussing common challenges that patients may face following IOLs implantation, such as visual halos, glare, or low contrast, and the means available to reduce these artifacts.

Nicole Fram, MD concludes this series on the potential of decentration and subsequent IOLs misalignment, highlighting zero and negative spherical aberration lens options for these unique cases.

Sydney Tyson, MD, MPH discusses various types of aspheric IOLs that cater to a patient’s lifestyle, highlighting recent developments in the therapeutic landscape like the CT Lucia 621P IOL.

Nicole Fram, MD discusses the methods for assessing a patients’ ocular anatomy for IOLs, such as corneal topography, ray tracing, and optical biometers.

Seth Pantanelli, MD discusses the landscape of monofocal aspheric intraocular lenses (IOLs) and how he caters treatment options to each patient.

Nicole Fram, MD discusses unique ocular anatomies, such as keratoconus or high myopia, that require specialized intraocular lens (IOLs) selection, highlighting the risks associated with IOLs calculation.

Seth Pantanelli, MD discusses the differences between traditional monofocal intraocular lenses (IOLs) and aspheric options.

The implantable lenses can offer an advantage over laser surgery.

Patients are encouraged to choose the optimal technology for their particular situation.

David Hutton of Ophthalmology Times talks with Eric Donnenfeld, MD about his presentation "Small Aperture IOL for Irregular Corneas" at this year's Hawaiian Eye and Retina 2024 Meeting.

Patient selection is important.

David Hutton of Ophthalmology Times talks with William Trattler, MD, about his presentation "Toric IOL pearls for Correcting Lower Levels of Astigmatism" at this year's Hawaiian Eye and Retina 2024 Meeting.

GreenMan app provides patients an opportunity to test drive various IOL options before cataract surgery via virtual and augmented reality.

A tailored treatment plan can help surgeons offer personalized care for patients.

EVO ICLs, which evolved from early generation ICLs, offer a lens-based alternative for the correction/reduction of refractive error in people who currently use glasses and/or contact lenses for vision correction.

AffaMed Technologies is the joint venture between AffaMed Therapeutics and SIFI.

The study monitored real-world patient experiences for up to 12 months post cataract surgery with implantation of either AcrySof IQ Vivity or AcrySof IQ Vivity Toric presbyopia-correcting intraocular lens (PCIOL).

Surgeons can refine their workflow, partner with an optometrist.

Lens is stable in capsular bag, less sensitive to misalignment.

Surgeons seek best IOL match for patients after cataract surgery.